ロード中...
20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma
Glioblastoma multiforme (GBM) is one of the most malignant human intracranial tumors. Temozolomide (TMZ) is the primary alkylating agent for GBM patients. However, many GBM patients are resistant to TMZ. Therefore, patients with GBM urgently need more effective therapeutic options. 20(S)‐ginsenoside...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6317960/ https://ncbi.nlm.nih.gov/pubmed/30431207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13881 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|